Phys Vivas · gastrointestinal
Acute Pancreatitis — Viva Defence
Structured DCE viva for acute pancreatitis: long-case defence of a 58-year-old man with severe alcohol-related necrotising pancreatitis complicated by infected walled-off necrosis, organ failure, new-onset diabetes, and malnutrition, covering the Revised Atlanta Classification severity, goal-directed Ringer lactate fluids after WATERFALL, early enteral nutrition, the step-up approach for infected necrosis after PANTER, and same-admission considerations. Plus branching scenarios into autoimmune pancreatitis (IgG4-related, steroid-responsive), hypertriglyceridaemic pancreatitis, and the abdominal examination short case.
On this page
Study tools
Target exams
Acute Pancreatitis — Viva Defence
Long case viva — severe necrotising alcohol-related pancreatitis
Candidate's opening statement (SASPOP)
"Doctor, my patient is a 58-year-old man who presented with severe acute pancreatitis, now on day 14 of his admission, complicated by persistent organ failure (acute kidney injury and respiratory compromise requiring high-flow nasal cannula), infected walled-off necrosis managed with endoscopic step-up drainage, and new-onset diabetes. He drinks approximately 80 grams of alcohol daily. His problems are: severe acute pancreatitis (Revised Atlanta severe) with infected walled-off necrosis; resolving multi-organ failure; malnutrition requiring nasojejunal feeding; alcohol use disorder; new-onset diabetes of the pancreas; and the need for rehabilitation and future alcohol and pancreatic surveillance." [1]
Problem list
- Severe necrotising pancreatitis with infected walled-off necrosis (managed with endoscopic drainage and antibiotics that penetrate necrosis).
- Resolving multi-organ failure (acute kidney injury recovering, respiratory compromise improving on high-flow nasal cannula).
- Malnutrition and ongoing catabolism (nasojejunal feeding at target rate).
- Alcohol use disorder (withdrawal risk, need for cessation counselling and thiamine).
- New-onset diabetes of the pancreas (pancreoprivic, likely brittle).
- Deconditioning and the need for rehabilitation. [1]
Integrated management plan
Source control. Continue endoscopic drainage of the walled-off necrosis via the established cystgastrostomy; repeat endoscopic necrosectomy if the collection re-accumulates or if clinical parameters deteriorate. Continue a carbapenem or piperacillin-tazobactam for the infected necrosis, with a plan to de-escalate and stop once source control is achieved and inflammatory markers settle. [4]
Fluid and organ support. Lactated Ringer's, WATERFALL moderate (10 mL per kg bolus only if hypovolaemic, then 1.5 mL per kg per hour), with reassessment at 12, 24, 48, and 72 hours. Aggressive bolus resuscitation causes fluid overload without benefit; I will avoid the 20 then 3 mL per kg regimen. Renal replacement therapy is on standby if the acute kidney injury worsens. High-flow nasal cannula for respiratory support, weaning as tolerated. [1]
Nutrition. Nasojejunal enteral feeding at target rate to achieve positive nitrogen balance. Multiple trials show early enteral feeding reduces infectious complications and mortality compared with NPO and parenteral nutrition. Plan to transition to an oral diet as ileus resolves. Pancreatic enzyme replacement for steatorrhoea from exocrine insufficiency. [4]
Diabetes. Endocrinology consultation. Pancreoprivic diabetes after necrotising pancreatitis is often brittle because of the loss of both insulin and glucagon counter-regulation, making hypoglycaemia dangerous. Likely requires insulin (basal-bolus regimen) with careful blood glucose monitoring and patient education about hypoglycaemia recognition. [1]
Alcohol use disorder. Parenteral then oral thiamine (Wernicke prevention). Benzodiazepines for withdrawal symptoms if they develop (CIWA-guided). Addiction medicine consultation for cessation counselling and planning for supervised detoxification after discharge. Counsel that continued drinking will cause recurrent attacks and progression to chronic pancreatitis with chronic pain, exocrine and endocrine insufficiency, and elevated pancreatic cancer risk. [1]
Rehabilitation. Early mobilisation, physiotherapy, and functional recovery. Deconditioning after a prolonged ICU stay is a major contributor to length of stay and morbidity. [1]
Examiner probing questions
Examiner: "Why did you choose Ringer lactate over normal saline, and what rate?" Ringer lactate is preferred over normal saline for three reasons: the WATERFALL trial established that moderately aggressive resuscitation is superior to aggressive bolus resuscitation; Ringer lactate reduces the systemic inflammatory response compared with normal saline; and normal saline causes hyperchloraemic metabolic acidosis, which may worsen splanchnic vasoconstriction and pancreatic perfusion. The rate I use is WATERFALL moderate: 10 mL per kg bolus only if hypovolaemic, then 1.5 mL per kg per hour, reassessed at 12, 24, 48, and 72 hours. I avoid the aggressive 20 then 3 mL per kg regimen. Wu 2011 supports lactated Ringer's over saline (SIRS 84 per cent reduction versus 0 per cent). [3]
Examiner: "Why no prophylactic antibiotics?" Prophylactic antibiotics are NOT recommended in acute pancreatitis, including in severe necrotising disease. Multiple randomised trials and meta-analyses confirm they do not reduce infected necrosis or mortality, and they increase fungal superinfection and antibiotic resistance. I use antibiotics only when infection is proven or strongly suspected — for this patient, the gas in the necrotic collection on CT was definitive evidence of infected necrosis, so antibiotics that penetrate necrosis are therapeutic, not prophylactic [2][10].
Examiner: "What is the step-up approach and what did PANTER show?" The step-up approach means treating infected necrosis with the least invasive effective intervention first, escalating only if that fails. The sequence is: antibiotics and supportive care; percutaneous or endoscopic catheter drainage; minimally invasive necrosectomy (endoscopic or VARD); and open necrosectomy as the last resort. The PANTER trial (van Santvoort, NEJM 2010) randomised 88 patients with infected necrosis to primary open necrosectomy versus the step-up approach. The step-up approach reduced the primary composite endpoint (major complications or death) from 69 to 40 per cent, and 35 per cent of patients needed drainage alone. ACG 2013: delay drainage in stable infected necrosis, preferably 4 weeks, to allow a wall to form. [10][4]
Examiner: "What are the revised Atlanta morphological terms and why do they matter?" Atlanta names peripancreatic fluid collections, necrosis (sterile or infected), pseudocyst, and walled-off necrosis. Mapping "pancreatic abscess" or "phlegmon" onto infected necrosis, and pairing the four names with a 4-week unwalled/walled clock, is exam convention — not an Atlanta-abstract sentence. ACG 2013 supplies the sourced 4-week delay for drainage in stable infected necrosis. [1][10][2]
Examiner: "Why does he have diabetes and what makes it different from type 2?" Necrotising pancreatitis destroys the endocrine pancreas. The resulting pancreoprivic (type 3c) diabetes is different from type 2 because it involves the loss of both insulin-secreting beta cells and glucagon-secreting alpha cells. Without glucagon counter-regulation, hypoglycaemia is more dangerous and the diabetes is brittle — difficult to control, with wide glucose excursions. Treatment requires insulin, but with caution and education about hypoglycaemia. Pancreatic enzyme replacement improves glycaemic control by restoring nutrient absorption and reducing the mismatch between insulin and absorbed glucose. [1]
References12ShowHide
- [1]Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus Gut, 2013.PMID 23100216
- [2]Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis Am J Gastroenterol, 2024.PMID 38857482
- [3]de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis N Engl J Med, 2022.PMID 36103415
- [4]van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis N Engl J Med, 2010.PMID 20410514
- [5]Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet, 2008.PMID 18279948
- [6]Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA The early prediction of mortality in acute pancreatitis: a large population-based study Gut, 2008.PMID 18519429
- [7]Hasibeder WR, Torgersen C, Rieger M Critical care of the patient with acute pancreatitis Anaesth Intensive Care, 2009.PMID 19400483
- [8]Davidson BR, Neoptolemos JP, Leese T Biochemical prediction of gallstones in acute pancreatitis: a prospective study of three systems Br J Surg, 1988.PMID 2450614
- [9]Moody N, Adiamah A, Yanni F, et al. Meta-analysis of randomized clinical trials of early versus delayed cholecystectomy for mild gallstone pancreatitis Br J Surg, 2019.PMID 31268184
- [10]Tenner S, Baillie J, DeWitt J, Vege SS American College of Gastroenterology guideline: management of acute pancreatitis Am J Gastroenterol, 2013.PMID 23896955
- [11]Vinish DB, Abishek V, Sujatha K Role of bedside pancreatic scores and C-reactive protein in predicting pancreatic fluid collections and necrosis Indian J Gastroenterol, 2017.PMID 28181127
- [12]Lee HW, Moon SH, Kim MH Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment J Gastroenterol, 2018.PMID 29362937